F
Closed
FAST-Trac Award
Funding for translational Angelman syndrome research
Last Update: April 27, 2026
Funding available
$ 150,000
Timeline
- Receipt of requests is now closed
Location
Canada
Overview
FAST-Trac Awards provide up to $150,000 per year for translational research in Angelman syndrome. The program supports therapeutic development, biomarkers, outcome measures, disease models, and clinical readiness activities.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Develop a new program or service
- Enhance an existing program
- Conduct research and development activities
Eligible Funding
- Maximum amount : 150,000 $
Timeline
- Receipt of requests is now closed
Eligible candidates
Eligible Industries
- Professional, scientific and technical services
Location
- Canada
Legal structures
- Non-profit
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Non-profit candidates
Sector of operation
- Research
Target groups
- People with disabilities
- Nonprofits / charities
- Academia / students
Revenue structures
- 100% donations / grants
Scope
- National
- International
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Translational research on potential Angelman syndrome treatments.
- Development of gene-modifying, disease-modifying, or symptom-alleviating therapeutics.
- High-throughput drug screening and novel disease model development.
- Biomarker and outcome measure development for clinical readiness.
- Preparation of clinical sites and natural history data collection.
Documents Needed
- Letter of Intent
- Research plan
- Budget justification
- Biographical sketch
- Other support information
Eligibility
Who is eligible?
- Nonprofit institutions.
- Research teams working on Angelman syndrome.
- Qualified individuals with PhD- or MD-level training.
Who is not eligible
- For-profit institutions.
- Applicants without PhD- or MD-level training.
Eligible expenses
- Reagents and materials, including cell lines and animal model lines.
- Specialized services such as sequencing, proteomics, metabolomics, and manufacturing.
- Specialized equipment or software needed for the project.
- Personnel costs, including salaries and fringe benefits.
- Travel support for the annual FAST scientific symposium.
Ineligible Costs and Activities
- Indirect costs on tuition, equipment, software, or software licenses.
- Travel costs beyond the included symposium stipend, unless not used and returned.
Processing and Agreement
- Applications are reviewed through scientific peer review by FAST’s Scientific Advisory Board.
- Applications are scored for scientific merit, innovation, translational impact, alignment with FAST’s mission, design, rationale, budget, and feasibility.
- SAB feedback may require applicant responses before final review.
- Funding recommendations move to the Scientific Director Panel and then to FAST’s Board of Directors for final approval.
- FAST aims to provide a funding response within six weeks of submission.
Additional information
- Applicants should submit a Letter of Intent before applying.
- Applications are accepted on a rolling basis.
- Final funding requires approval by FAST’s Board of Directors.
- Projects with human or animal subjects require IRB or IACUC approval before funds are released.
Contacts
Frequently Asked Questions about the FAST-Trac Award Program
Here are answers to the most common questions about the FAST-Trac Award. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.
What is the FAST-Trac Award?
FAST-Trac Awards provide up to $150,000 per year for translational research in Angelman syndrome. The program supports therapeutic development, biomarkers, outcome measures, disease models, and clinical readiness activities.
How much funding can be received?
FAST-Trac Award Funds up to $150,000 of admissible expenses.
Who is eligible for the FAST-Trac Award program?
To be eligible for the FAST-Trac Award program, you must:
Nonprofit institutions only.
PhD- or MD-level applicants.
Full-time research commitment.
What expenses are eligible under FAST-Trac Award?
Translational research on potential Angelman syndrome treatments.
Development of gene-modifying, disease-modifying, or symptom-alleviating therapeutics.
High-throughput drug screening and novel disease model development.
Biomarker and outcome measure development for clinical readiness.
Preparation of clinical sites and natural history data collection.
Who can I contact for more information about the FAST-Trac Award?
You can contact Foundation for Angelman Syndrome Therapeutics (FAST) by email at grants@cureangelman.org or by phone at 630-852-3278.
Where is the FAST-Trac Award available?
The FAST-Trac Award program is available across Canada.
Who are the financial supporters of the FAST-Trac Award?
FAST-Trac Award is funded by Foundation for Angelman Syndrome Therapeutics (FAST)